Knowledge Management System Of Shanghai Institute of Applied Physics, CAS
| [Re-188]rhenium sulfide suspension: A potential radiopharmaceutical for tumor treatment following intra-tumor injection | |
| Yu, JF（于俊锋）; Yin, DZ（尹端沚）; Min, XF; Guo, ZL; Zhang, J; Wang, YX; Knapp, FF | |
| 1999 | |
| Source Publication | NUCLEAR MEDICINE AND BIOLOGY
 |
| ISSN | 0969-8051 |
| Volume | 26Issue:5Pages:573 |
| Abstract | Intralesional therapy has been shown to be an effective treatment for tumors. In this study, the suitability of [Re-188]rhenium sulfide suspension for tumor treatment following intra-tumor injection was evaluated. The [Re-188]rhenium sulfide suspension was radiolabeled with Re-188 with a radiochemical yield of more than 96%. In vitro stability studies revealed that more than 99% of the Re-188 remained in sulfide form over a 3-day period. After ultrasonication for 5 or 10 min, the main particle size was 1-5 mu m. Two [Re-188]rhenium sulfide suspensions ultrasonicated for 5 and 10 min, respectively, were injected into separate group of tumor-bearing mice that were killed after specified times to compare the retention of Re-188 in tumors and the leakage to different organs by periods and organs removed to gamma counting. The mean retention percentages of Re-188 in tumors injected with suspension ultrasonicated for 5 (or 10) min were as follows: 1 h, 90.5 +/- 7.7% (83.1 +/- 13.7%); 24 h, 92.2 +/- 8.6% (83.9 +/- 9.8%); 48 h, 88.3 +/- 10.9% (80.2 +/- 3.8%); and 72 h, 91.5 +/- 7.6% (78.8 +/- 3.0%). Tumor-inhibiting ratio was 96.5%. These results demonstrated that [Re-188]rhenium sulfide suspension is an effective radiopharmaceutical for tumor treatment by intralesional therapy. (C) 1999 Elsevier Science Inc. All rights reserved. |
| Indexed By | SCI |
| Language | 英语 |
| Funding Project | 应物所项目组 |
| WOS ID | WOS:000081586800012 |
| Citation statistics | |
| Document Type | 期刊论文 |
| Identifier | http://ir.sinap.ac.cn/handle/331007/9841 |
| Collection | 中科院上海原子核所2003年前 |
| Recommended Citation GB/T 7714 | Yu, JF,Yin, DZ,Min, XF,et al. [Re-188]rhenium sulfide suspension: A potential radiopharmaceutical for tumor treatment following intra-tumor injection[J]. NUCLEAR MEDICINE AND BIOLOGY,1999,26(5):573. |
| APA | Yu, JF.,Yin, DZ.,Min, XF.,Guo, ZL.,Zhang, J.,...&Knapp, FF.(1999).[Re-188]rhenium sulfide suspension: A potential radiopharmaceutical for tumor treatment following intra-tumor injection.NUCLEAR MEDICINE AND BIOLOGY,26(5),573. |
| MLA | Yu, JF,et al."[Re-188]rhenium sulfide suspension: A potential radiopharmaceutical for tumor treatment following intra-tumor injection".NUCLEAR MEDICINE AND BIOLOGY 26.5(1999):573. |
| Files in This Item: | ||||||
| File Name/Size | DocType | Version | Access | License | ||
| [Re-188]rhenium sulf（794KB） | 开放获取 | -- | View Application Full Text | |||
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment